CATX
Perspective Therapeutics Inc.
2.50$
-4.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -164.3% | – | -890.4% | – | – | – | – | – | – | – | |
| – | +1.2% | +35.9% | +60.7% | +17.0% | +7.8% | +1.5% | +0.1% | +5.7% | +30.5% | +11.4% | +1.3% | – | |
| – | +59.6% | -8.9% | +9.6% | +171.5% | +5.5% | +1.8% | +14.5% | -10.3% | +7.1% | +10.6% | +19.3% | – | |
| – | – | +1,183.9% | -94.3% | +1,019.8% | -170.0% | – | – | – | -90.6% | -1,344.0% | – | – | |
| – | -60.8% | +10,093.3% | -88.8% | +2,827.4% | -50.8% | -68.1% | -78.0% | +94.2% | +154.8% | +35.1% | +107.0% | – | |
| – | -60.8% | +53,042.7% | -93.0% | +802.5% | +366.1% | -96.0% | – | +228.1% | +104.0% | -483.9% | – | – | |
| – | – | – | – | – | -25.0% | +8.3% | +0.0% | +0.0% | +0.0% | +15.4% | -13.3% | – | |
| – | +35,100.0% | +47,152.3% | -26.6% | -99.5% | -45.1% | +2,790.7% | -98.7% | +61.4% | -106.1% | – | -99.9% | – | |
| – | – | – | -17.3% | -123.4% | – | – | – | – | – | +503.6% | -123.5% | – | |
| – | – | – | -307.6% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.